speb/financial-data huggingface dataset:
CGNX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 169000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Other Properties: 166191000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Other Receivables: 2755000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 56703000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Payables: 65980000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 133829000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CGNX income_statement (quarterly, 2025-03-31) — Pretax Income: 27798000.00
CGNX cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: -2587000.00
CGNX cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
CGNX cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -113297000.00
CGNX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -2501000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Raw Materials: 80628000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Receivables: 163940000.00
CGNX income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 71713000.00
CGNX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 7934000.00
CGNX cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -102233000.00
CGNX income_statement (quarterly, 2025-03-31) — Research And Development: 34727000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 405949000.00
CGNX cash_flow (quarterly, 2025-03-31) — Sale Of Business: 0.00
CGNX cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 148885000.00
CGNX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 83504000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Share Issued: 167864778.00
CGNX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 9939000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1445628000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 964565000.00
CGNX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 231948.88
CGNX income_statement (quarterly, 2025-03-31) — Tax Provision: 4195000.00
CGNX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
CGNX balance_sheet (quarterly, 2025-03-31) — Total Assets: 1932503000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1445628000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Total Debt: 73702000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1445628000.00
CGNX income_statement (quarterly, 2025-03-31) — Total Expenses: 189944000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 486875000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1354824000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 302911000.00
CGNX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 26092000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 22677000.00
CGNX income_statement (quarterly, 2025-03-31) — Total Unusual Items: 1537000.00
CGNX income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 1537000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Work In Process: 5500000.00
CGNX balance_sheet (quarterly, 2025-03-31) — Working Capital: 393715000.00
CGNX income_statement (quarterly, 2025-06-30) — +Operating Expense: 124443000.00
CGNX income_statement (quarterly, 2025-06-30) — +Total Revenue: 249093000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 42273000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 183946000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1110458000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -620000.00
CGNX cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 2678000.00
CGNX cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 2678000.00
CGNX cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -153000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 324348000.00
CGNX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 167886000.00
CGNX income_statement (quarterly, 2025-06-30) — Basic EPS: 0.24
CGNX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 143744000.00
CGNX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -2194000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 83185000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 336000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 179311000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 228203000.00
CGNX cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -13431000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 27949000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Cash Financial: 151362000.00
CGNX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -13256000.00
CGNX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -3966000.00
CGNX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 42625000.00
CGNX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -1421000.00
CGNX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 8395000.00
CGNX cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: -17449000.00
CGNX cash_flow (quarterly, 2025-06-30) — Change In Inventory: 7470000.00
CGNX cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 11236000.00
CGNX cash_flow (quarterly, 2025-06-30) — Change In Payable: -18870000.00
CGNX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -10475000.00
CGNX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -4890000.00
CGNX cash_flow (quarterly, 2025-06-30) — Change In Receivables: -20355000.00
CGNX cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: -17449000.00
CGNX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -17014000.00
CGNX cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -20949000.00
CGNX cash_flow (quarterly, 2025-06-30) — Changes In Cash: 25403000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Common Stock: 336000.00
CGNX cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -13431000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1506057000.00
CGNX cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
CGNX income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 81217000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 78344000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Current Assets: 625725000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 11260000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 11260000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 53077000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 53077000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 190437000.00
CGNX cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -1504000.00
CGNX cash_flow (quarterly, 2025-06-30) — Deferred Tax: -1504000.00
CGNX cash_flow (quarterly, 2025-06-30) — Depreciation: 5321000.00
CGNX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 7999000.00
CGNX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 7999000.00
CGNX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 168563000.00
CGNX income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.24
CGNX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 40511000.00
CGNX income_statement (quarterly, 2025-06-30) — EBIT: 43433000.00
CGNX income_statement (quarterly, 2025-06-30) — EBITDA: 51432000.00
CGNX cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 10164000.00
CGNX cash_flow (quarterly, 2025-06-30) — End Cash Position: 179311000.00
CGNX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -13256000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Finished Goods: 59300000.00
CGNX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 40431000.00
CGNX cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -27000.00
CGNX cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 6000.00
CGNX income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 2537000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -37777000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Goodwill: 397389000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 489524000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 184566000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 171418000.00
CGNX income_statement (quarterly, 2025-06-30) — Gross Profit: 167876000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 5483000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Inventory: 144577000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1506057000.00
CGNX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -3966000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 324348000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 324348000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 71925000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 71925000.00
CGNX cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
CGNX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
CGNX income_statement (quarterly, 2025-06-30) — Net Income: 40511000.00
CGNX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 40511000.00
CGNX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 40511000.00
CGNX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 40511000.00
CGNX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 40511000.00
CGNX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 40511000.00
CGNX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 40511000.00
CGNX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -1772000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Net PPE: 171418000.00
CGNX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -2194000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1016533000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 387232000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 235031000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 387232000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 235031000.00
CGNX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 48895000.00
CGNX income_statement (quarterly, 2025-06-30) — Normalized Income: 38379920.00
CGNX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 42625000.00
CGNX cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -21000.00
CGNX income_statement (quarterly, 2025-06-30) — Operating Income: 43433000.00
CGNX income_statement (quarterly, 2025-06-30) — Operating Revenue: 249093000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 167899010.00
CGNX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 66823000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -37777000.00
CGNX income_statement (quarterly, 2025-06-30) — Other Income Expense: 4629000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 92135000.00
CGNX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 701000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 5294000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 91000.00
CGNX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 2092000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Other Properties: 171418000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Other Receivables: 2176000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 48892000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Payables: 47756000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 126100000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CGNX income_statement (quarterly, 2025-06-30) — Pretax Income: 48062000.00
CGNX cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 175000.00
CGNX cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
CGNX cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -101457000.00
CGNX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -2194000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Raw Materials: 78836000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Receivables: 186122000.00
CGNX income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 81217000.00
CGNX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 7999000.00
CGNX cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
CGNX income_statement (quarterly, 2025-06-30) — Research And Development: 33102000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 433040000.00
CGNX cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 99685000.00
CGNX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 91341000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Share Issued: 167899010.00
CGNX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 12294000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1506057000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1016533000.00
CGNX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 405920.00
CGNX income_statement (quarterly, 2025-06-30) — Tax Provision: 7551000.00
CGNX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.16
CGNX balance_sheet (quarterly, 2025-06-30) — Total Assets: 2003541000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1506057000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Total Debt: 83185000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1506057000.00
CGNX income_statement (quarterly, 2025-06-30) — Total Expenses: 205660000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 497484000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1377816000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 307047000.00
CGNX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 43433000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 5483000.00
CGNX income_statement (quarterly, 2025-06-30) — Total Unusual Items: 2537000.00
CGNX income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 2537000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Work In Process: 6441000.00
CGNX balance_sheet (quarterly, 2025-06-30) — Working Capital: 435288000.00
CGNX income_statement (quarterly, 2025-09-30) — +Operating Expense: 129525000.00
CGNX income_statement (quarterly, 2025-09-30) — +Total Revenue: 276892000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 45480000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 154612000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1123134000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -732000.00
CGNX cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 2639000.00
CGNX cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 2639000.00
CGNX cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -125000.00
CGNX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 167840000.00
CGNX income_statement (quarterly, 2025-09-30) — Basic EPS: 0.11
CGNX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 179311000.00
CGNX cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1452000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 78925000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 335000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 245898000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 300266000.00
CGNX cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -13443000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 93445000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Cash Financial: 152453000.00
CGNX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -37571000.00
CGNX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 18503000.00
CGNX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 87485000.00
CGNX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 3352000.00
CGNX cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 8189000.00
CGNX cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: -2636000.00
CGNX cash_flow (quarterly, 2025-09-30) — Change In Inventory: -1066000.00
CGNX cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -28772000.00
CGNX cash_flow (quarterly, 2025-09-30) — Change In Payable: 716000.00
CGNX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 8905000.00
CGNX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 11219000.00
CGNX cash_flow (quarterly, 2025-09-30) — Change In Receivables: 14001000.00
CGNX cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: -2636000.00
CGNX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 4287000.00
CGNX cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 28718000.00
CGNX cash_flow (quarterly, 2025-09-30) — Changes In Cash: 68417000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Common Stock: 335000.00
CGNX cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -13443000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1489636000.00
CGNX cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -24000000.00
CGNX income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 89602000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 86708000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Current Assets: 670919000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 10613000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 10613000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 23767000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 23767000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 169273000.00
CGNX cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 43934000.00
CGNX cash_flow (quarterly, 2025-09-30) — Deferred Tax: 43934000.00
CGNX cash_flow (quarterly, 2025-09-30) — Depreciation: 4894000.00
CGNX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 7533000.00
CGNX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 7533000.00
CGNX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 169323000.00
CGNX income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.10
CGNX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 17664000.00
CGNX income_statement (quarterly, 2025-09-30) — EBIT: 57765000.00
CGNX income_statement (quarterly, 2025-09-30) — EBITDA: 65298000.00
CGNX cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -1830000.00
CGNX cash_flow (quarterly, 2025-09-30) — End Cash Position: 245898000.00
CGNX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -37571000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Finished Goods: 58985000.00
CGNX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 86033000.00
CGNX cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -96000.00
CGNX cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 0.00
CGNX income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 5037000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -46180000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Goodwill: 392084000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 478835000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 155344000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 164050000.00
CGNX income_statement (quarterly, 2025-09-30) — Gross Profit: 187290000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 2705000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Inventory: 143679000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1489636000.00
CGNX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 18503000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 300078000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 68312000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 68312000.00
CGNX cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
CGNX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -24000000.00
CGNX income_statement (quarterly, 2025-09-30) — Net Income: 17664000.00
CGNX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 17664000.00
CGNX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 17664000.00
CGNX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 17664000.00
CGNX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 17664000.00
CGNX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 17664000.00
CGNX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 17664000.00
CGNX cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 19955000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Net PPE: 164050000.00
CGNX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1452000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1010801000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 383611000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 275441000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 383611000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 275441000.00
CGNX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 60261000.00
CGNX income_statement (quarterly, 2025-09-30) — Normalized Income: 13684770.00
CGNX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 87485000.00
CGNX cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -96000.00
CGNX income_statement (quarterly, 2025-09-30) — Operating Income: 57765000.00
CGNX income_statement (quarterly, 2025-09-30) — Operating Revenue: 276892000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 167549000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 55453000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -46180000.00
CGNX income_statement (quarterly, 2025-09-30) — Other Income Expense: 5098000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 86751000.00
CGNX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 1872000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 5257000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 88000.00
CGNX income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 61000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Other Properties: 164050000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Other Receivables: 16909000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 54368000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Payables: 48185000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 134893000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CGNX income_statement (quarterly, 2025-09-30) — Pretax Income: 62863000.00
CGNX cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 260000.00
CGNX cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
CGNX cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -34717000.00
CGNX cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1452000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Raw Materials: 79683000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Receivables: 171521000.00
CGNX income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 89602000.00
CGNX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 7533000.00
CGNX cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -24000000.00
CGNX income_statement (quarterly, 2025-09-30) — Research And Development: 35081000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 412347000.00
CGNX cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 54672000.00
CGNX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 94444000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Share Issued: 167549000.00
CGNX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 12416000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1489636000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1010801000.00
CGNX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 1057770.00
CGNX income_statement (quarterly, 2025-09-30) — Tax Provision: 45199000.00
CGNX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CGNX balance_sheet (quarterly, 2025-09-30) — Total Assets: 2002750000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1489636000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Total Debt: 78925000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1489636000.00
CGNX income_statement (quarterly, 2025-09-30) — Total Expenses: 219127000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 513114000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1331831000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 343841000.00
CGNX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 57765000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 2705000.00
CGNX income_statement (quarterly, 2025-09-30) — Total Unusual Items: 5037000.00
CGNX income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 5037000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Work In Process: 5011000.00
CGNX balance_sheet (quarterly, 2025-09-30) — Working Capital: 501646000.00
CGNX income_statement (annual, 2025-12-31) — +Operating Expense: 502827000.00
CGNX income_statement (quarterly, 2025-12-31) — +Operating Expense: 130628000.00
CGNX income_statement (annual, 2025-12-31) — +Total Revenue: 994359000.00
CGNX income_statement (quarterly, 2025-12-31) — +Total Revenue: 252338000.00
CGNX balance_sheet (annual, 2025-12-31) — Accounts Payable: 50203000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 50203000.00
CGNX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 146713000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 146713000.00
CGNX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -140000000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -140000000.00
CGNX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1138708000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1138708000.00
CGNX balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -728000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -728000.00
CGNX cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 10504000.00
CGNX cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 2559000.00
CGNX cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 10504000.00
CGNX cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 2559000.00
CGNX cash_flow (annual, 2025-12-31) — Amortization Of Securities: -731000.00
CGNX cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -292000.00
CGNX balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 4182000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 4182000.00
CGNX income_statement (annual, 2025-12-31) — Basic Average Shares: 168049000.00
CGNX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 167256000.00
CGNX income_statement (annual, 2025-12-31) — Basic EPS: 0.68
CGNX income_statement (quarterly, 2025-12-31) — Basic EPS: 0.20
CGNX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 186094000.00
CGNX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 245898000.00
CGNX balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 79206000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 79206000.00
CGNX cash_flow (annual, 2025-12-31) — Capital Expenditure: -8743000.00
CGNX cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -2596000.00
CGNX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 76586000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 76586000.00
CGNX balance_sheet (annual, 2025-12-31) — Capital Stock: 334000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 334000.00
CGNX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 262925000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 262925000.00
CGNX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 336962000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 336962000.00
CGNX cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -54627000.00
CGNX cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -14203000.00
CGNX balance_sheet (annual, 2025-12-31) — Cash Equivalents: 63170000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 63170000.00
CGNX balance_sheet (annual, 2025-12-31) — Cash Financial: 199755000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Cash Financial: 199755000.00
CGNX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -206693000.00
CGNX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -37496000.00
CGNX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 28016000.00
CGNX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -19608000.00
CGNX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 245514000.00
CGNX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 74902000.00
CGNX cash_flow (annual, 2025-12-31) — Change In Account Payable: 11707000.00
CGNX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 4780000.00
CGNX cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 15957000.00
CGNX cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 5428000.00
CGNX cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: -16806000.00
CGNX cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: 6432000.00
CGNX cash_flow (annual, 2025-12-31) — Change In Inventory: 4863000.00
CGNX cash_flow (quarterly, 2025-12-31) — Change In Inventory: -7015000.00
CGNX cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -4401000.00
CGNX cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -3659000.00
CGNX cash_flow (annual, 2025-12-31) — Change In Payable: -5099000.00
CGNX cash_flow (quarterly, 2025-12-31) — Change In Payable: 11212000.00
CGNX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 10858000.00
CGNX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 16640000.00
CGNX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 5655000.00
CGNX cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -3200000.00
CGNX cash_flow (annual, 2025-12-31) — Change In Receivables: -15227000.00
CGNX cash_flow (quarterly, 2025-12-31) — Change In Receivables: 8003000.00
CGNX cash_flow (annual, 2025-12-31) — Change In Tax Payable: -16806000.00
CGNX cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: 6432000.00
CGNX cash_flow (annual, 2025-12-31) — Change In Working Capital: 1748000.00
CGNX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 10769000.00
CGNX cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -1358000.00
CGNX cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 8056000.00
CGNX cash_flow (annual, 2025-12-31) — Changes In Cash: 66837000.00
CGNX cash_flow (quarterly, 2025-12-31) — Changes In Cash: 17798000.00
CGNX balance_sheet (annual, 2025-12-31) — Common Stock: 334000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Common Stock: 334000.00
CGNX cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -54627000.00
CGNX cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -14203000.00
CGNX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1491901000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1491901000.00
CGNX cash_flow (annual, 2025-12-31) — Common Stock Payments: -151233000.00
CGNX cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -25000000.00
CGNX income_statement (annual, 2025-12-31) — Cost Of Revenue: 328966000.00
CGNX income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 86434000.00
CGNX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 39509000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 39509000.00
CGNX balance_sheet (annual, 2025-12-31) — Current Assets: 697246000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Current Assets: 697246000.00
CGNX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 11716000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 11716000.00
CGNX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 11716000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 11716000.00
CGNX balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 21094000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 21094000.00
CGNX balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 21094000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 21094000.00
CGNX balance_sheet (annual, 2025-12-31) — Current Liabilities: 183551000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 183551000.00
CGNX balance_sheet (annual, 2025-12-31) — Current Provisions: 5474000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Current Provisions: 5474000.00
CGNX cash_flow (annual, 2025-12-31) — Deferred Income Tax: 40147000.00
CGNX cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 2406000.00
CGNX cash_flow (annual, 2025-12-31) — Deferred Tax: 40147000.00
CGNX cash_flow (quarterly, 2025-12-31) — Deferred Tax: 2406000.00
CGNX cash_flow (annual, 2025-12-31) — Depreciation: 20289000.00
CGNX cash_flow (quarterly, 2025-12-31) — Depreciation: 4768000.00
CGNX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 30793000.00
CGNX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 7327000.00
CGNX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 30793000.00
CGNX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 7327000.00
CGNX income_statement (annual, 2025-12-31) — Diluted Average Shares: 169367000.00
CGNX income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 168896000.00
CGNX income_statement (annual, 2025-12-31) — Diluted EPS: 0.68
CGNX income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.19
CGNX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 114442000.00
CGNX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 32664000.00
CGNX income_statement (annual, 2025-12-31) — EBIT: 162566000.00
CGNX income_statement (quarterly, 2025-12-31) — EBIT: 35276000.00
CGNX income_statement (annual, 2025-12-31) — EBITDA: 193359000.00
CGNX income_statement (quarterly, 2025-12-31) — EBITDA: 42603000.00
CGNX cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 9994000.00
CGNX cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -771000.00
CGNX cash_flow (annual, 2025-12-31) — End Cash Position: 262925000.00
CGNX cash_flow (quarterly, 2025-12-31) — End Cash Position: 262925000.00
CGNX cash_flow (annual, 2025-12-31) — Financing Cash Flow: -206693000.00
CGNX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -37496000.00
CGNX balance_sheet (annual, 2025-12-31) — Finished Goods: 57595000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Finished Goods: 57595000.00
CGNX cash_flow (annual, 2025-12-31) — Free Cash Flow: 236771000.00
CGNX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 72306000.00
CGNX cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -156000.00
CGNX cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -6000.00
CGNX cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -4889000.00
CGNX cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: -4895000.00
CGNX income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 12868000.00
CGNX income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 3757000.00
CGNX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -53496000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -53496000.00
CGNX balance_sheet (annual, 2025-12-31) — Goodwill: 386279000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Goodwill: 386279000.00
CGNX balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 467379000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 467379000.00
CGNX balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 147441000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 147441000.00
CGNX balance_sheet (annual, 2025-12-31) — Gross PPE: 298325000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 298325000.00
CGNX income_statement (annual, 2025-12-31) — Gross Profit: 665393000.00
CGNX income_statement (quarterly, 2025-12-31) — Gross Profit: 165904000.00
CGNX balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 301157000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 301157000.00
CGNX balance_sheet (annual, 2025-12-31) — Income Tax Payable: 9141000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 9141000.00
CGNX balance_sheet (annual, 2025-12-31) — Inventory: 137889000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Inventory: 137889000.00
CGNX balance_sheet (annual, 2025-12-31) — Invested Capital: 1491901000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1491901000.00
CGNX cash_flow (annual, 2025-12-31) — Investing Cash Flow: 28016000.00
CGNX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -19608000.00
CGNX balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 305339000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 305339000.00
CGNX balance_sheet (annual, 2025-12-31) — Investments And Advances: 305339000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 305339000.00
CGNX balance_sheet (annual, 2025-12-31) — Land And Improvements: 8018000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 8018000.00
CGNX balance_sheet (annual, 2025-12-31) — Leases: 22702000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Leases: 22702000.00
CGNX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 64870000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 64870000.00
CGNX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 64870000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 64870000.00
CGNX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 66624000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 66624000.00
CGNX cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
CGNX cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
CGNX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -151233000.00
CGNX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -25000000.00
CGNX income_statement (annual, 2025-12-31) — Net Income: 114442000.00
CGNX income_statement (quarterly, 2025-12-31) — Net Income: 32664000.00
CGNX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 114442000.00
CGNX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 32664000.00
CGNX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 114442000.00
CGNX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 32664000.00
CGNX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 114442000.00
CGNX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 32664000.00
CGNX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 114442000.00
CGNX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 32664000.00
CGNX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 114442000.00
CGNX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 32664000.00
CGNX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 114442000.00
CGNX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 32664000.00
CGNX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 30055000.00
CGNX cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -23716000.00
CGNX cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -388000.00
CGNX cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
CGNX balance_sheet (annual, 2025-12-31) — Net PPE: 158325000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Net PPE: 158325000.00
CGNX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -2039000.00
CGNX cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 4108000.00
CGNX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 1024522000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 1024522000.00
CGNX balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 383272000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 383272000.00
CGNX balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 274781000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 274781000.00
CGNX balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 383272000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 383272000.00
CGNX balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 274781000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 274781000.00
CGNX income_statement (annual, 2025-12-31) — Normalized EBITDA: 180491000.00
CGNX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 38846000.00
CGNX income_statement (annual, 2025-12-31) — Normalized Income: 106386072.52
CGNX income_statement (quarterly, 2025-12-31) — Normalized Income: 29879938.47
CGNX cash_flow (annual, 2025-12-31) — Operating Cash Flow: 245514000.00
CGNX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 74902000.00
CGNX cash_flow (annual, 2025-12-31) — Operating Gains Losses: -5045000.00
CGNX cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -4901000.00
CGNX income_statement (annual, 2025-12-31) — Operating Income: 162566000.00
CGNX income_statement (quarterly, 2025-12-31) — Operating Income: 35276000.00
CGNX income_statement (annual, 2025-12-31) — Operating Revenue: 994359000.00
CGNX income_statement (quarterly, 2025-12-31) — Operating Revenue: 252338000.00
CGNX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 166997000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 166997000.00
CGNX balance_sheet (annual, 2025-12-31) — Other Current Assets: 58702000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 58702000.00
CGNX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -53496000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -53496000.00
CGNX income_statement (annual, 2025-12-31) — Other Income Expense: 20236000.00
CGNX income_statement (quarterly, 2025-12-31) — Other Income Expense: 8803000.00
CGNX balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 81100000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 81100000.00
CGNX cash_flow (annual, 2025-12-31) — Other Non Cash Items: 15643000.00
CGNX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 13061000.00
CGNX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 4994000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 4994000.00
CGNX balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 1452000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 1452000.00
CGNX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 7368000.00
CGNX income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 5046000.00
CGNX balance_sheet (annual, 2025-12-31) — Other Properties: 121775000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Other Properties: 121775000.00
CGNX balance_sheet (annual, 2025-12-31) — Other Receivables: 16980000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Other Receivables: 16980000.00
CGNX balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 74037000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 74037000.00
CGNX balance_sheet (annual, 2025-12-31) — Payables: 59344000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Payables: 59344000.00
CGNX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 98853000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 98853000.00
CGNX balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 46414000.00
CGNX balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 46414000.00